JUVE Patent has published its new JUVE Patent Rankings Germany 2026. We are delighted that Maiwald has once again been listed in all three key categories: Patent Filing, Litigation: Patent Attorneys and Litigation: Lawyers.
The JUVE Patent rankings are based on independent research conducted by a specialised editorial team. The assessment includes market analysis, questionnaires and interviews with clients, competitors, lawyers, patent attorneys and other market participants.
In its editorial commentary, JUVE once again highlights Maiwald’s strong mixed approach: the firm has a well-established and broad prosecution practice and is also highly active in patent disputes. Maiwald remains particularly visible in pharmaceutical and biotech patent cases, including on the side of generics and biosimilar manufacturers. At the same time, JUVE notes that the litigation team is increasingly establishing itself in technical fields beyond the life sciences sector.
JUVE identifies Maiwald’s strengths as litigation with technical expertise in biotech, pharmaceuticals and chemicals, as well as the firm’s excellent US contacts.
Several individuals are also specifically recommended in the 2026 rankings: Dr. Marco Stief, Dr. Dirk Bühler, Dr. Eva Ehlich and Dr. Regina Neuefeind. Dr. Marco Stief is described as a “thoroughly reliable advisor for all IP issues and contract law in the life sciences sector” and as an “outstanding contract lawyer and litigator who knows every detail and trick”.
We would like to thank our clients and peers for their trust and recognition, and our entire team for their excellent work.
More information on the rankings is available here:
